Hispanic Heritage Month and Psychedelics
Celebrate National Hispanic Heritage Month by expressing gratitude for Hispanic and Latinx visionaries, researchers, community members, and others who have expanded awareness about psychedelics. Taking …
Participant Safety in Psychedelic Therapy
All stakeholders at the Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MAPS PBC) are committed to providing quality and comprehensive training and supervision …
MAPS and Vine Ventures Pioneer Novel Regenerative Funding Structure to Infuse Psychedelic-Assisted Therapy Research and Access With Timely $70 Million
Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once …
The Guardian: Psychedelics Can Change Humanity for the Better. It’s Time to Unlock Their Power
In an op-ed published by The Guardian, MAPS Founder Rick Doblin, Ph.D., explores how advancing scientific understanding of psychedelic therapies offers hope for achieving mass mental health. Doblin illustrates …
MDMA Therapy Training Program Update: November 2021
The fall MDMA Therapy Training cohort is now underway and includes approximately 500 trainees in a 100-hour online program, running through December 18, 2021. So far this year we’ve granted $900,000 …
Investigator-Initiated Trials Recruitment: The Influence of MDMA on the Reward Circuits in the Human Brain of Healthy Individuals
Dr. Leanne Williams and a team of researchers at Stanford University in Stanford, California, are using fMRI to study how MDMA impacts the reward circuits of the human brain of healthy individuals. This …
Investigator-Initiated Trials Recruitment: A Phase 1 Study on the Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress Disorder
Dr. Benjamin Kelmendi and a team of researchers at Yale University in New Haven, Connecticut, are studying the effects of MDMA on prefrontal and amygdala activation in individuals with posttraumatic stress …
Investigator-Initiated Trials Recruitment: A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for PTSD
Dr. Anne Wagner and a team of researchers at Remedy Institute in Toronto, Canada are conducting a treatment development study of MDMA-assisted cognitive processing therapy (CPT) for individuals with posttraumatic …
An Open-Label Feasibility and Safety Study of MDMA-Assisted Group Therapy for the Treatment of Posttraumatic Stress Disorder in Veterans
MAPS is sponsoring a Phase 2, open-label protocol to assess the feasibility and safety of MDMA-assisted group therapy for the treatment of PTSD in Veterans. The study will be conducted in up to 18 participants, …
First Participant Consented to Participation in A Phase 2, Open-Label, Randomized Comparative Effectiveness Study for MDMA-Assisted Psychotherapy in U.S. Military Veterans with Chronic PTSD
MAPS is sponsoring a Phase 2, open-label protocol to study the comparative effectiveness of two vs. three MDMA-assisted therapy sessions in Veterans with PTSD at the James J. Peters Veterans Affairs (VA) …
October 2021 Giving Report: Donors Give Over $287,000 to Psychedelic Research and Education
In October 2021, over 1,400 donors gave $287,368 in donations and pledges. We are so grateful to these supporters who advance our shared vision of creating safe and legal opportunities for the beneficial …
Information for People Seeking Training in Psychedelic-Assisted Therapy
The psychedelic research renaissance, initially funded only by philanthropy and government grants, is generating increasingly promising data about therapeutic applications, and new understandings of the …